COVID-19 induced ARDS Intensive care unit treatment (participation in DIVI ECMO COVID Register) ECMO therapy during intensive care U99.0 J12.8 Z11 Z20.8
Conditions
Interventions
Group 1: This is a German multicenter study for the investigation of clinical characteristics, management and outcomes of Covid-19 ARDS patients in cooperation between the German ARDS network and the
German Interdisciplinary Association for Intensive Care and Emergency Medicine).
The project aims to improve the understanding of short-term disease history of patients with COVID-19, to identify pos
Sponsors
Klinik für Anästhesiologie, Universitätsklinikum Würzburg (UKW)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: COVID-19 induced ARDS Intensive care unit treatment (participation in DIVI ECMO COVID Register) ECMO therapy during intensive care
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical characteristics, management and survival of ARDS patients with COVID-19 and ECMO in Germany. | — |
Secondary
| Measure | Time frame |
|---|---|
| ECMO management, ventilation parameters, anticoagulation management, as well as frequency and influencing factors of co- and super-infections, thromboembolic events and bleeding of ARDS patients with COVID-19 and ECMO. | — |
Countries
Germany
Contacts
Public ContactPatrick Meybohm
Klinik für Anästhesiologie, Universitätsklinikum Würzburg (UKW)
Outcome results
None listed